With Woodcock’s Retirement, US FDA Loses A Renaissance Woman

FDA will go on without Janet Woodcock, but it will likely take multiple people to fill in the gaps given her breadth of institutional knowledge, interests and skill sets, former close colleagues say.

Janet Woodcock
• Source: Getty Images

Janet Woodcock will retire from the US Food and Drug Administration in early 2024 after more than 35 years at the agency, she confirmed recently.

More from Regulation

More from Policy & Regulation